OMC
IMA

Oasis Management Company’s ImageneBio Inc IMA Stock Holding History

Oasis Management Company’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,667
Closed -$372K – 90
2022
Q4 		$372K Hold
11,667
– – 0.07% 75
2022
Q3 		$497K Hold
11,667
– – 0.08% 83
2022
Q2 		$620K Buy
+11,667
New +$644K 0.11% 76

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Oasis Management Company's IMA Position: Q1 2023 in Review

Oasis Management Company sold out of ImageneBio Inc (IMA) in Q1 2023, closing a stake of 11,667 shares — an estimated $372K sold.

Oasis Management Company first reported a position in IMA in Q2 2022 and held it in 3 quarters. The position peaked at $620K in Q2 2022. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2023.

  • Oasis Management Company reported no remaining ImageneBio Inc position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 11,667 ImageneBio Inc shares in Q1 2023, an estimated $372K.
  • Oasis Management Company first reported a position in ImageneBio Inc in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's ImageneBio Inc position peaked at $620K in Q2 2022.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.